For instance, it has been demonstrated to enhance the expression of CPT1 and adipose triglyceride lipase, both of which are essential for maintaining lipid homeostasis (Fang et al
Research-grade only products are supplied with no warranties or representations regarding safety, efficacy, or suitability for any purpose outside of controlled research environments
During phase 1 trials in NASH patients, efocipegtrutide showed a half-life of around 5.9 days, and was capable of reducing body weight by 5.1% when administered weekly at 0.08mg/kg, after 12 weeks [36]
8(12): 26959 Berthele A, Boxall SJ, Urban A, et al
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population